<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03952117</url>
  </required_header>
  <id_info>
    <org_study_id>LAUMCRH.RA3.11/Apr/2019</org_study_id>
    <nct_id>NCT03952117</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation of the Motor Cortex in Essential Tremor</brief_title>
  <official_title>Transcranial Direct Current Stimulation of the Motor Cortex in Essential Tremor : A Randomized Controlled Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lebanese American University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lebanese American University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current research is aimed at using Transcranial Direct Current Stimulation (tDCS) as&#xD;
      complementary therapeutic tool in the treatment of essential tremor. Patients will be&#xD;
      randomized into two groups (tDCS-cathode vs. tDCS-sham) according to detailed protocol. Main&#xD;
      outcome will be measured by the change in tremor amplitude using an accelerometer pre and&#xD;
      post cathodal tDCS of the motor cortex.&#xD;
&#xD;
      A total of 40 patients ought to be enrolled as specified in methodology. Secondary outcomes&#xD;
      will assess TRG essential tremor rating assessment scale (TETRAS) as well as clinical&#xD;
      monitoring.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Essential tremor (ET) is a common progressive neurological disorder and is the most common&#xD;
      movement disorder. Worldwide , up to 5% of the population suffer from this disorder with an&#xD;
      increased incidence with advanced age.&#xD;
&#xD;
      The proposed mechanism that underlies ET, the central oscillating network, is mainly composed&#xD;
      of the olivocerebellar system, thalamus and motor cortex. An interruption in this circuit&#xD;
      limits the ability of the cortex to reorganize and restore ET. a case of 76 year old female&#xD;
      with essential tremor that disappeared following a cortico-subcortical prerolandic stroke&#xD;
      despite complete motor recovery highlights the role of the motor cortex in the production and&#xD;
      possible therapeutic role of the transcranial direct current stimulation.&#xD;
&#xD;
      Study design A randomized, sham-controlled, double blind and crossover study.&#xD;
&#xD;
      Study procedure:&#xD;
&#xD;
      The first visit is an inclusion visit Prior to starting the first tDCS session, the patient&#xD;
      will be asked to fill his/her first TRG essential tremor assessment (TETRAS) scale. The&#xD;
      physician will then quantitatively analyze the tremor on the most affected side using an&#xD;
      accelerometer. Cathodal tDCS will be administered on the area representing the primary motor&#xD;
      cortex and the anode over the contralateral supraorbital area. tDCS stimulation (cathodal and&#xD;
      sham) will be done daily for 5 consecutive days during weeks 1 and 5. Each stimulation&#xD;
      session will last 30 minutes. tDCS will be performed while the patient is at rest, without&#xD;
      any concurrent cognitive or motor task.The two tDCS sessions will be separated by a 23 day&#xD;
      washout period.&#xD;
&#xD;
      Patient will be asked to fill out their TETRAS at days 1 and 5 of each tDCS session (cathodal&#xD;
      and sham), and days 12 and 19 after each tDCS session (cathodal and sham).&#xD;
&#xD;
      Accelerometer assessment of the tremor will be performed at days 1 and 5 of each tDCS&#xD;
      stimulation session (cathodal and sham).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 19, 2019</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tremor amplitude</measure>
    <time_frame>5 days</time_frame>
    <description>Change in tremor amplitude using an accelerometer pre and post cathodal tDCS of the motor cortex.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional impact of tremor</measure>
    <time_frame>19 days</time_frame>
    <description>Assess change from baseline of the functional impact of tremor using the TETRAS scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Essential Tremor</condition>
  <condition>Transcranial Direct Current Stimulation</condition>
  <arm_group>
    <arm_group_label>Active tDCs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active tDCS will be administered through a pair of conductive rubber electrodes covered by saline soaked sponges (35 cm2). The current will be delivered continuously at 2 mA for 30 min through a battery-driven constant-current stimulator. The cathode will be positioned facing the primary motor cortex area and the anode over the contralateral supraorbital area.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham stimulation will be delivered to the motor cortex using a sham tDCS device that delivers a direct current for 10 seconds at the beginning and end of tDCS to provide sensory experiences similar to active stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial direct current stimulation</intervention_name>
    <description>tDCS will be administered through a pair of conductive rubber electrodes covered by saline soaked sponges (35 cm2). The current will be delivered continuously at 2 mA for 30 min through a battery-driven constant-current stimulator (Sooma Oy, Helsinki, Finland).</description>
    <arm_group_label>Active tDCs</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Patients who fulfil the 2017 Movement society concusses statement criteria for essential&#xD;
        tremor&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Isolated focal tremor (voice, head)&#xD;
&#xD;
          -  Orthostatic tremor with a frequency of more than 12 Hz&#xD;
&#xD;
          -  Task and position specific tremor&#xD;
&#xD;
          -  Sudden onset and stepwise deterioration of tremor&#xD;
&#xD;
          -  History of substance abuse or dependence in the past&#xD;
&#xD;
          -  Co-morbid medical conditions capable of producing or enhancing tremors&#xD;
&#xD;
          -  Use of a medication with potential effect on tremor&#xD;
&#xD;
          -  History of neurological disorders, brain tumors, brain surgery or abnormal&#xD;
             neurological examination&#xD;
&#xD;
          -  Epileptic disorders&#xD;
&#xD;
          -  Cardiac pacemakers&#xD;
&#xD;
          -  Metallic hardware in the head or scalp (surgical clips)&#xD;
&#xD;
          -  Eczema or skin abrasion at the intended site of stimulation&#xD;
&#xD;
          -  Currently pregnant or plan for pregnancy in the next 6 months&#xD;
&#xD;
          -  Patients with prior experience with tDCS&#xD;
&#xD;
          -  Major psychosocial problems or medical problems rendering informed consent impossible&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rechdi Ahdab</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lebanese American University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Naji Riachi, MD</last_name>
    <phone>009611200800</phone>
    <phone_ext>6312</phone_ext>
    <email>Naji.riachi@lau.edu.lb</email>
  </overall_contact>
  <location>
    <facility>
      <name>LAUMCRH</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naji Riachi, MD</last_name>
      <phone>009611200800</phone>
      <phone_ext>6312</phone_ext>
      <email>Naji.riachi@lau.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>May 14, 2019</study_first_submitted>
  <study_first_submitted_qc>May 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2019</study_first_posted>
  <last_update_submitted>August 12, 2019</last_update_submitted>
  <last_update_submitted_qc>August 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Lebanese American University</investigator_affiliation>
    <investigator_full_name>Rechdi Ahdab</investigator_full_name>
    <investigator_title>M.D , PhD</investigator_title>
  </responsible_party>
  <keyword>primary motor cortex</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Essential Tremor</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 11, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/17/NCT03952117/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

